Could a DNA-Busting enzyme ease tough asthma?
NCT ID NCT03994380
First seen Apr 25, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This pilot study tested whether inhaling a drug called rh-DNase for 4 weeks helps adults with neutrophilic asthma, a type of asthma with high inflammation. Nineteen participants took part to see if the treatment improved lung function and symptom control. The goal was to find a new way to ease breathing and reduce asthma attacks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUTROPHILIC ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Jewish Health
Denver, Colorado, 80206, United States
Conditions
Explore the condition pages connected to this study.